Article citationsMore>>

H. Azimi, A. A. Khakshur, I. Aghdasi, M. Fallah-Tafti and M. A. Abdollahi, “Review of Animal and Human Studies for Management of Benign Prostatic Hyperplasia with Natural Products; Perspective of new Pharmacological Agents,” Inflammation & Allergy—Drug Targets, Vol. 11, No. 3, 2012, pp. 207-221. doi:10.2174/187152812800392715

has been cited by the following article:

• TITLE: Saw Palmetto-Based Nutritional Supplement Prostataplex Relieves Symptoms of Benign Prostatic Hyperplasia (BPH) in Patients with Mild to Moderate BPH

  AUTHORS: Qingwen Xie, Jing Leng, Jianwei Lv, Allan Pantuck, Lawrence Yen, Mina Shariff, Kenneth Kami, Jianyu Rao, Rong Shi

  KEYWORDS: Saw Palmetto, Prostataplex; Benign Prostatic Hyperplasia; Intervention

  JOURNAL NAME: Open Journal of Urology, Vol.2 No.3, August 28, 2012

  ABSTRACT: The goal of this study was to assess the efficacy of the saw palmetto-based nutritional supplement, Prostataplex, for relieving the symptoms associated with benign prostatic hyperplasia (BPH) in men with mild to moderate degrees of BPH. A randomized, double-blind, placebo-controlled trial was performed in Shanghai, China. Eighty patients with BPH were randomly assigned to either the intervention group (39 cases) or control group (41 cases). Patients in the intervention group were administered Prostataplex orally and placebos were given to patients in the control group. The duration of treatment was 12 weeks in both groups. Following the intervention of Prostataplex, the maximum urinary flow rates (MFR), total scores of International Prostate Symptom Score (IPSS) and quality of life indicators were significantly better among the patients in the intervention group than those in the control group (P